[13] De Soyza A， et al. Bronchiectasis rheumatoid overlap syndrome (BROS) is an independent risk factor for mortality in patients with bronchiectasis： a multicentre cohort study. Chest. 2017;151(6)：1247-54.
[14] Chalmers JD， et al. The bronchiectasis severity index an international derivation and validation study. Am J Respir Critic Care Med. 2014;189(5)：576–85.
[15] Martinez-Garcia MA， et al. Multidimensional approach to non-cystic fibrosis bronchiectasis： the FACED score. Eur Respir J. 2014;43：1357–67.
[16] McDonnell MJ， et al. Multidimensional severity assessment in bronchiectasis： an analysis of seven European cohorts. Thorax. 2016;71：1110–8.
[17] 高曉华，冷敏，徐向英， 等.支气管扩张症营养不良患者门诊干预的分析[J].中华肺部疾病杂志(电子版)， 2017，(1)：73-74.
[18] McDonnell MJ， et al. Non cystic fibrosis bronchiectasis： a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med. 2015;109(6)：716–26.
[19] McCullough AR， et al. Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmon Med. 2014;14：107.
[20] Haworth CS， et al. Inhaled colistin in patients with bronchiectasis and chronic pseudomonas infection. Am J Respir Crit Care Med. 2014;189(8)：975–82.
[21] Mitchell-Wagg K， et al. A self-management program of activity coping and exercise (SPACE) for COPD： results from a randomised controlled trial. Thorax. 2012;67 supplement II：A25.
[22] Hester KLM， et al. Living your life with bronchiectasis： an exploration of patients and carers information needs informing development of a novel information resource. Thorax. 2015;70(Supplement 3)：P201.
[23] Panagioti M， et al. Self-management support interventions to reduce health care utilisation without compromising outcomes： a systematic review and meta-analysis. BMC Health Serv Res. 2014;14：356.
[24] Patient Information Forum， Making the case for information. 2013., http://www.100md.com(夏琼 韩莉 冯钰惠)